Attorney Matthew Bilinsky and Republican California delegate Roxanne Hoge join ‘Fox News @ Night’ to discuss the fired L.A. city workers trying to get their jobs back after vaccine mandates.
Twice-yearly shots used to treat AIDS were 100% effective in preventing new infections in women, according to a new study. There were no infections among the young women and girls who received the shots in a study of about 5,000 participants in South Africa and Uganda. The shots, made by U.
S. drugmaker Gilead and sold as Sunlenca, are currently approved as a treatment for HIV in several regions. Twice-yearly shots used to treat AIDS were 100% effective in preventing new infections in women, according to study results published Wednesday.
There were no infections in the young women and girls that got the shots in a study of about 5,000 in South Africa and Uganda, researchers reported. In a group given daily prevention pills, roughly 2% ended up catching HIV from infected sex partners. "To see this level of protection is stunning," said Salim Abdool Karim of the injections.
He is director of an AIDS research center in Durban, South Africa, who was not part of the research. PIONEER OF AMERICA'S GLOBAL HIV/AIDS PROGRAM RECALLS HOPE AFTER YEARS OF DESPAIR The shots made by U.S.
drugmaker Gilead and sold as Sunlenca are approved in the U.S., Canada, Europe and elsewhere, but only as a treatment for HIV .
The company said it is waiting for results of testing in men before seeking permission .